Nath Bio-Genes (India) Balance Sheet Health
Financial Health criteria checks 4/6
Nath Bio-Genes (India) has a total shareholder equity of ₹6.0B and total debt of ₹1.1B, which brings its debt-to-equity ratio to 18.7%. Its total assets and total liabilities are ₹8.5B and ₹2.4B respectively. Nath Bio-Genes (India)'s EBIT is ₹481.0M making its interest coverage ratio 5.4. It has cash and short-term investments of ₹152.3M.
Key information
18.7%
Debt to equity ratio
₹1.13b
Debt
| Interest coverage ratio | 5.4x |
| Cash | ₹152.27m |
| Equity | ₹6.04b |
| Total liabilities | ₹2.43b |
| Total assets | ₹8.47b |
Recent financial health updates
Nath Bio-Genes (India) (NSE:NATHBIOGEN) Seems To Use Debt Quite Sensibly
Aug 05
We Think Nath Bio-Genes (India) (NSE:NATHBIOGEN) Is Taking Some Risk With Its Debt
Aug 27Nath Bio-Genes (India) (NSE:NATHBIOGEN) Has A Pretty Healthy Balance Sheet
Feb 24Is Nath Bio-Genes (India) (NSE:NATHBIOGEN) A Risky Investment?
Feb 28These 4 Measures Indicate That Nath Bio-Genes (India) (NSE:NATHBIOGEN) Is Using Debt Reasonably Well
Nov 26Recent updates
Nath Bio-Genes (India) (NSE:NATHBIOGEN) Has More To Do To Multiply In Value Going Forward
Apr 05Returns On Capital At Nath Bio-Genes (India) (NSE:NATHBIOGEN) Have Hit The Brakes
Oct 24Nath Bio-Genes (India) (NSE:NATHBIOGEN) Seems To Use Debt Quite Sensibly
Aug 05Nath Bio-Genes (India) (NSE:NATHBIOGEN) Has Some Way To Go To Become A Multi-Bagger
Jun 07Some Investors May Be Worried About Nath Bio-Genes (India)'s (NSE:NATHBIOGEN) Returns On Capital
Feb 11We Think Nath Bio-Genes (India) (NSE:NATHBIOGEN) Is Taking Some Risk With Its Debt
Aug 27Nath Bio-Genes (India)'s (NSE:NATHBIOGEN) Returns On Capital Not Reflecting Well On The Business
Jun 19Nath Bio-Genes (India) (NSE:NATHBIOGEN) Has A Pretty Healthy Balance Sheet
Feb 24Returns On Capital Signal Tricky Times Ahead For Nath Bio-Genes (India) (NSE:NATHBIOGEN)
May 27Is Nath Bio-Genes (India) (NSE:NATHBIOGEN) A Risky Investment?
Feb 28The Trends At Nath Bio-Genes (India) (NSE:NATHBIOGEN) That You Should Know About
Feb 07Declining Stock and Decent Financials: Is The Market Wrong About Nath Bio-Genes (India) Limited (NSE:NATHBIOGEN)?
Jan 19The Nath Bio-Genes (India) (NSE:NATHBIOGEN) Share Price Is Up 149% And Shareholders Are Boasting About It
Jan 01Why Nath Bio-Genes (India)'s (NSE:NATHBIOGEN) CEO Pay Matters
Dec 14
These 4 Measures Indicate That Nath Bio-Genes (India) (NSE:NATHBIOGEN) Is Using Debt Reasonably Well
Nov 26Here's What To Make Of Nath Bio-Genes (India)'s (NSE:NATHBIOGEN) Returns On Capital
Nov 05Do Its Financials Have Any Role To Play In Driving Nath Bio-Genes (India) Limited's (NSE:NATHBIOGEN) Stock Up Recently?
Oct 15Nath Bio-Genes (India) Limited (NSE:NATHBIOGEN) Might Not Be As Mispriced As It Looks After Plunging 25%
Sep 24Many Still Looking Away From Nath Bio-Genes (India) Limited (NSE:NATHBIOGEN)
Sep 08Introducing Nath Bio-Genes (India) (NSE:NATHBIOGEN), The Stock That Soared 311% In The Last Five Years
Sep 07Nath Bio-Genes (India) Limited (NSE:NATHBIOGEN) Doing What It Can To Lift Shares
Aug 18Here's What We Think About Nath Bio-Genes (India)'s (NSE:NATHBIOGEN) CEO Pay
Jul 26Is Nath Bio-Genes (India) (NSE:NATHBIOGEN) Likely To Turn Things Around?
Jul 09Financial Position Analysis
Short Term Liabilities: NATHBIOGEN's short term assets (₹5.8B) exceed its short term liabilities (₹2.4B).
Long Term Liabilities: NATHBIOGEN's short term assets (₹5.8B) exceed its long term liabilities (₹33.4M).
Debt to Equity History and Analysis
Debt Level: NATHBIOGEN's net debt to equity ratio (16.2%) is considered satisfactory.
Reducing Debt: NATHBIOGEN's debt to equity ratio has increased from 9.7% to 18.7% over the past 5 years.
Debt Coverage: NATHBIOGEN's debt is not well covered by operating cash flow (13%).
Interest Coverage: NATHBIOGEN's interest payments on its debt are well covered by EBIT (5.4x coverage).